Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XL
1076
DELISTED
XL Group Ltd.
XL
| $9.66M | 0.01% |
244,782
+2,627
| +1% | +$112K |
|
|
RHT
1077
PUT
DELISTED
Red Hat Inc
RHT
| $9.63M | 0.01% |
86,900
+50,500
| +139% | +$5.17M |
|
1078
CALL
Ionis Pharmaceuticals
IONS
$8.6B
| $9.63M | 0.01% |
190,000
+9,200
| +5% | +$482K |
|
1079
CALL
AB InBev
BUD
$170B
| $9.57M | 0.01% |
80,200
+51,400
| +178% | +$6.02M |
|
|
HTZ
1080
CALL
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $9.56M | 0.01% |
492,214
+238,488
| +94% | +$3.76M |
|
|
SINA
1081
PUT
DELISTED
Sina Corp
SINA
| $9.53M | 0.01% |
83,100
-9,500
| -10% | -$960K |
|
1082
Domino's
DPZ
$11.5B
| $9.49M | 0.01% |
47,791
+38,849
| +434% | +$7.56M |
|
1083
Jack Henry & Associates
JKHY
$10.9B
| $9.46M | 0.01% |
92,084
-5,957
| -6% | -$617K |
|
|
TIF
1084
DELISTED
Tiffany & Co.
TIF
| $9.45M | 0.01% |
102,955
+31,191
| +43% | +$2.86M |
|
|
NLSN
1085
DELISTED
Nielsen Holdings plc
NLSN
| $9.42M | 0.01% |
227,301
+109,779
| +93% | +$4.38M |
|
|
TTM
1086
DELISTED
Tata Motors Limited
TTM
| $9.41M | 0.01% |
300,892
+179,635
| +148% | +$5.78M |
|
|
JUNO
1087
PUT
DELISTED
Juno Therapeutics, Inc.
JUNO
| $9.41M | 0.01% |
209,700
-36,100
| -15% | -$1.23M |
|
|
XYZ
1088
PUT
Block Inc
XYZ
$48.4B
| $9.38M | 0.01% |
325,700
+301,000
| +1,219% | +$7.88M |
|
1089
MiMedx Group
MDXG
$602M
| $9.38M | 0.01% |
789,322
+748,698
| +1,843% | +$11.1M |
|
|
EXAS
1090
CALL
DELISTED
Exact Sciences
EXAS
| $9.35M | 0.01% |
198,500
+51,400
| +35% | +$2.07M |
|
1091
PUT
Direxion Daily Financial Bull 3x ETF
FAS
$2.44B
| $9.35M | 0.01% |
167,000
+24,200
| +17% | +$1.25M |
|
1092
Live Nation Entertainment
LYV
$40.6B
| $9.35M | 0.01% |
214,595
+8,906
| +4% | +$346K |
|
1093
PUT
Ford
F
$58.5B
| $9.32M | 0.01% |
778,700
-43,700
| -5% | -$493K |
|
1094
Church & Dwight Co
CHD
$23.4B
| $9.3M | 0.01% |
191,924
+22,877
| +14% | +$1.16M |
|
1095
CALL
Energy Transfer Partners
ET
$70.1B
| $9.29M | 0.01% |
534,300
-339,900
| -39% | -$5.95M |
|
1096
Sun Life Financial
SLF
$46B
| $9.28M | 0.01% |
233,131
-4,094
| -2% | -$156K |
|
1097
Vanguard FTSE Europe ETF
VGK
$30.7B
| $9.28M | 0.01% |
159,136
+55,368
| +53% | +$3.14M |
|
1098
PUT
Neurocrine Biosciences
NBIX
$16.8B
| $9.27M | 0.01% |
151,300
+58,800
| +64% | +$3.1M |
|
1099
Omega Healthcare
OHI
$15.1B
| $9.25M | 0.01% |
289,758
+206,627
| +249% | +$6.62M |
|
1100
Western Midstream Partners
WES
$19.2B
| $9.24M | 0.01% |
224,455
+40,627
| +22% | +$1.66M |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.